Stocks · Korea
253840
KOSDAQ
Sugentech
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+10.23%
1M+12.40%
3M+28.31%
6M+1.68%
1Y-34.37%
YTD-24.57%
52W high8,250원
52W low3,530원
From 52W high-41.21%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,014억 | 250억 | 267억 | 24.6% |
| 2023 | 71억 | -228억 | -174억 | -319.1% |
| 2024 | 101억 | -220억 | -154억 | -218.1% |
| 2025 | 94억 | -188억 | -235억 | -199.9% |
| Quarterly | ||||
| 2024 4Q | 25억 | -77억 | -88억 | -310.7% |
| 2025 1Q | 19억 | -40억 | -31억 | -210.2% |
| 2025 2Q | 32억 | -49억 | -53억 | -154.1% |
| 2025 3Q | 15억 | -48억 | -38억 | -326.6% |
| 2025 4Q | 29억 | -51억 | -113억 | -178.2% |
| 2026 1Q | 23억 | -47억 | -43억 | -199.6% |
Company
Address: 대전광역시 유성구 테크노2로 206 사무동2층 수젠텍
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-05-13수젠텍, 한타바이러스 美·유럽 확산에 5% 상승 [Why 바이오] 서울경제
- 2026-04-20다시 불어닥친 감염병 진단·백신 테마풍…진원생명과학·수젠텍 '上'... 이데일리
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.